Abbvie is a general drug manufacturer company located in Illinois, United States, which is part of the Healthcare sector, and is traded under the ticker ABBV on the NYSE exchange.
Abbvie stock last closed at $212.40, up 0.38% from the previous day, and has increased 18.1% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.14 percentage points. Abbvie stock is currently +26.02% from its 52-week low of $168.54, and -13.24% from its 52-week high of $244.81.
As of Apr 9, 2026, there are 1.77B shares of ABBV outstanding. The market value of ABBV is $375.56B. In the last 24 hours, 2.43M ABBV shares were traded.
How to Buy Abbvie Stock
Not sure how to invest in Abbvie stock? Here's how.
Figure out where to buy Abbvie stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Abbvie stock.
Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Select your method of payment and add your details.
Evaluate Abbvie stock: The Abbvie ticker symbol is ABBV. Is Abbvie stock a good investment? Should you buy shares of ABBV? How do ABBV's underlying business fundamentals look? Do top analysts think Abbvie is a good buy? Why has ABBV's stock price moved recently? (Hint: Our stock research website can help you decide if ABBV is a good stock to buy).
Execute your ABBV purchase: Decide if you will purchase ABBV shares at the current market price or use a limit order to buy ABBV stock at a given price.
Keep tabs on your investment in ABBV: Create a watchlist to watch your investment in Abbvie stock.
Step 1: Figure out where to buy Abbvie stock
You need a brokerage account in order to access the NYSE market and buy ABBV shares.
A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you are able to invest in ABBV stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Abbvie stock
After you have figured out the best place to buy Abbvie stock, it's important to research their stock before you buy, so you can comprehend the risk as well as the opportunity.
Abbvie Numbers
ABBV Price
$212.40
1w %
1.7%
1y %
18.1%
5y %
97.51%
P/E
89.62x
P/B
-114.85x
P/S
6.14x
PEG
0.92x
Revenue
$61.16B
Earnings
$4.23B
Fore. Rev. Growth
9.08%
Fore. Earn. Growth
97.03%
Market Cap
$375.56B
Next Earnings
Apr 23, 2026
Next Dividend
May 15, 2026
Abbvie Overview
WallStreetZen was created to help part-time investors perform better fundamental analysis quickly.
ABBV's operating cash flow of $19.03B allows it to safely service it's debt of $67.50B.
Failed Health Checks:
There are more long-term liabilities than short-term assets on the ABBV balance sheet.
ABBV profit margin has gone down from 7.6% to 6.9% in the past year.
There are more short-term liabilities than short-term assets on the ABBV balance sheet.
ABBV earnings of $9.22B is not enough to cover its interest payments.
Total ABBV debt is still negative.
ABBV debt to equity ratio of -41.95 is negative.
Is ABBV stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 14 sell side analysts who give ratings on ABBV, the consensus analyst rating on Abbvie is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent ABBV Analyst Upgrades/Downgrades
Michael Yee, a top 13% analyst from UBS maintains ABBV with a hold rating and lowers their ABBV price target from $240.00 to $230.00, on Feb 5, 2026.
Gavin Clark-Gartner, a bottom 10% analyst from Evercore ISI Group maintains ABBV with a buy rating and lowers their ABBV price target from $232.00 to $228.00, on Feb 5, 2026.
Terence Flynn, a top 8% analyst from Morgan Stanley maintains ABBV with a strong buy rating and raises their ABBV price target from $269.00 to $270.00, on Feb 5, 2026.
Geoff Meacham, a top 10% analyst from Citigroup maintains ABBV with a hold rating and lowers their ABBV price target from $235.00 to $230.00, on Jan 27, 2026.
Rajesh Kumar, a top 31% analyst from HSBC upgrades ABBV to a strong buy rating and raises their ABBV price target from $225.00 to $265.00, on Dec 10, 2025.
You can dive deeper into what analysts are forecasting on the Abbvie stock forecast page.
ABBV Technicals
SMA10
211.2
SMA20
211.76
SMA50
220.7
SMA100
223.24
SMA200
216.65
MACD
-3.31
MACD Signal
-3.78
MACD Histogram
0.47
RSI
46.67
Stochastic %K
45.02
Stochastic %D
34.97
StochRSI %K
69.53
StochRSI %D
58.1
ABBV Performance Numbers
Last year, ABBV earnings were $4.23B. Over the last 5 year, ABBV's earnings have grown by -2.79% per year. This was slower than the Drug Manufacturers - General industry average of 19.58%.
Last year, ABBV revenue was $61.16B. Over the past five year, ABBV's revenue has grown by 5.95% per year. This was slower than the Drug Manufacturers - General industry average of 10.04%.
Abbvie pays a dividend of 3.13%, compared to the Drug Manufacturers - General industry's average dividend yield of 2.69%. If you owned $1,000 worth of ABBV stock, you would have received $31.31 in the past 12 months.
Abbvie dividend payments have consistently grown over the past decade and have remained stable.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your ABBV purchase
There are two main options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually the easiest way to buy.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a given price limit, place a limit order.
Press the Open Trade button and your broker will place the order.
If you require additional assistance investing in stocks on eToro, click the how to video below:
As of Apr 9, 2026, it costs $212.40 to buy one share of Abbvie stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.471 shares of ABBV.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.